Synergistic interaction of levetiracetam with gabapentin in the mouse 6 Hz psychomotor seizure model – a type II isobolographic analysis

1. Barton M.E. et al.: Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res., 47, 217, 2001.10.1016/S0920-1211(01)00302-3Search in Google Scholar

2. Deckers C.L.P. et al.: Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia, 41, 1364, 2000.10.1111/j.1528-1157.2000.tb00111.x11077449Search in Google Scholar

3. Dooley D.J., Taylor C.P., Donevan S., Feltner D.: Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol. Sci., 28, 75, 2007. Erratum in: Trends Pharmacol. Sci., 28, 151, 2007.Search in Google Scholar

4. Dudra-Jastrzebska M. et al.: Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. Eur. J. Pharmacol., 605, 87, 2009.10.1016/j.ejphar.2008.12.04619168049Search in Google Scholar

5. Fisher R.S. et al.: ILAE official report: a practical clinical definition of epilepsy. Epilepsia, 55, 475, 2014.10.1111/epi.1255024730690Search in Google Scholar

6. Florek-Łuszczki M., Wlaź A., Łuszczki J.J.: Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model - A type II isobolographic analysis. Eur. J. Pharmacol., 723, 410, 2014.Search in Google Scholar

7. Kwan P., Brodie M.J.: Combination therapy in epilepsy: when and what to use. Drugs, 66, 1817, 2006.Search in Google Scholar

8. Litchfield J.T., Wilcoxon F.: A simplified method of evaluating doseeffect experiments. J. Pharmacol. Exp. Ther., 96, 99, 1949.Search in Google Scholar

9. Łuszczki J.J., Czuczwar S.J.: Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis. Epilepsia, 45, 895, 2004.Search in Google Scholar

10. Łuszczki J.J. et al.: Additive interaction of levetiracetam with lamotrigine in the mouse 6 Hz psychomotor seizure model - an isobolographic analysis. Curr. Issues Pharm. Med. Sci., 26, 82, 2013.10.12923/j.2084-980X/26.1/a.18Search in Google Scholar

11. Łuszczki J.J. et al.: Interactions of levetiracetam with ethosuximide in the mouse 6 Hz psychomotor seizure model - a type II isobolographic analysis. J. Pre-Clin. Clin. Res., 8, 76, 2014.10.26444/jpccr/71472Search in Google Scholar

12. Łuszczki J.J. et al.: Isobolographic characterization of interaction of levetiracetam with clobazam in the mouse 6 Hz psychomotor seizure model. J. Pre-Clin. Clin. Res., 6, 25, 2012.Search in Google Scholar

13. Lynch B.A. et al.: The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. USA, 101, 9861, 2004.10.1073/pnas.030820810147076415210974Search in Google Scholar

14. Perucca E.: Pharmacological principles as a basis for polytherapy. Acta Neurol. Scand., Suppl. 162, 31, 1995.10.1111/j.1600-0404.1995.tb00497.x7495187Search in Google Scholar

15. Shandra A. et al.: Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice. Epilepsia, 54, 1167, 2013.10.1111/epi.1223723750855Search in Google Scholar

16. Tallarida R.J., (2000). Drug synergism and dose-effect data analysis. Chapman & Hall/CRC, Boca Raton.10.1201/9781420036107Search in Google Scholar

17. Wojda E. et al.: Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model. Epilepsy Res., 86, 163, 2009. 10.1016/j.eplepsyres.2009.06.00319596559Search in Google Scholar